Telomeric Repeat-Containing RNA Increases in Aged Human Cells
Abstract
Telomeric repeat-containing RNA (TERRA), transcribed from subtelomeric regions towards telomeric ends, poses challenges in deciphering its complete sequences. Utilizing TERRA-capture RNA-seq and Oxford Nanopore direct RNA sequencing to acquire full-length TERRA, we annotate TERRA transcription regions in the human T2T-CHM13 reference genome. TERRA transcripts encompass hundreds to over a thousand nucleotides of telomeric repeats, predominantly originating from 61-29-37 bp repeat promoters enriched with H3K4me3, RNA pol II, CTCF, and R-loops. We develop a bioinformatics tool, TERRA-QUANT, for quantifying TERRA using RNA-seq datasets and find that TERRA increases with age in blood, brain, and fibroblasts. TERRA upregulation in aged leukocytes is confirmed by RT-qPCR. Single-cell RNA-seq analysis demonstrates TERRA expression across various cell types, with upregulation observed in neurons during human embryonic stem cell differentiation. Additionally, TERRA levels are elevated in brain cells in the early stage of Alzheimers disease. Our study provides evidence linking TERRA to human aging and diseases.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper investigates the role of telomeric repeat-containing RNA (TERRA) in the context of aging and its potential implications in age-related diseases, specifically Alzheimer's disease. While it provides insights into the molecular changes associated with aging, it does not directly address the root causes of aging or propose mechanisms for lifespan extension. The findings contribute to the understanding of aging processes, but the impact is limited as it primarily focuses on the correlation of TERRA levels with age rather than offering transformative solutions or interventions.
Author of this paper? Send a correction.